You are here

cancer

Saving pediatric cancer drugs from the ‘valley of death’

Beckers Hospital Review

Fri, 05/16/25 - 11:23 am

drug development

In first oncology expert meeting under Makary, FDA spotlights cancer drugs from J&J, Pfizer, Roche and UroGen

Fierce Pharma

Thu, 05/8/25 - 10:56 pm

UK unveils £1B plan to become leading cancer research hub just outside the Golden Triangle

Fierce Biotech

Fri, 05/2/25 - 11:19 am

AACR 2025: Quintet of investigational oncological drugs puts Ascentage on positive ascent

Pharmaphorum

Tue, 04/29/25 - 08:11 am

Ascentage Pharma

Caribou, in reversal, scraps autoimmune cell therapy and cuts staff

BioPharma Dive

Fri, 04/25/25 - 11:19 am

Caribou Biosciences

Mosaic adds to cancer combo pattern by licensing 2 clinical-stage drugs from Astex

Fierce Biotech

Thu, 04/24/25 - 10:50 am

Mosaic Therapeutics

Astex Pharmaceuticals

German cancer antibody biotech eyes SPAC as route to Nasdaq

Fierce Biotech

Wed, 04/23/25 - 11:02 am

Boehringer to expand oncology presence with $572m Tessellate Bio deal

Pharmaceutical Technology

Wed, 04/23/25 - 09:42 am

Boehringer Ingelheim

Jobevne (Bevacizumab) Gains FDA Nod, Biocon Expands US Oncology Biosimilars Portfolio

Xtalks

Sun, 04/13/25 - 11:15 pm

bevacizumab-nwgd

Biocon Biologics

As Trump Cuts Cancer Research Funding, Billionaire Sean Parker Wants To Scale It Up

Forbes

Mon, 03/31/25 - 10:53 am

Parker Institute for Cancer Immunotherapy

FDA rejects Hengrui, Elevar's PD-1 cancer drug combination—again

Fierce Pharma

Sun, 03/23/25 - 11:43 pm

Jiangsu Hengrui

Elevar Therapeutics

Gene therapy loses luster as investors eye quicker returns from weight-loss drugs

Yahoo/Reuters

Fri, 03/21/25 - 11:42 am

drug development

Cell therapy biotech Century Therapeutics axes cancer trial, turns to autoimmune

Fierce Biotech

Thu, 03/20/25 - 11:11 am

Century Therapeutics

autoimmune diseases

Lilly backs precision medicine start-up’s $65 million raise

Chemical and Engineering News

Wed, 03/19/25 - 11:16 am

Ampersand Biosciences

Flagship Pioneering

Nanobiotix tweaks J&J licensing deal for phase 3 cancer drug to eke out cash

Fierce Biotech

Tue, 03/18/25 - 11:17 am

head and neck cancer

AstraZeneca signs Alteogen deal worth up to $1.35B for subcutaneous cancer drugs despite Merck-Halozyme patent drama

Fierce Pharma

Mon, 03/17/25 - 10:11 pm

subcutaneous drug delivery

Labcorp is buying Bioreference health’s cancer testing business for $192m

MedCity News

Sun, 03/16/25 - 09:52 pm

BioReference Labs

This Could Be the Catalyst That Sends Summit Therapeutics' Stock Higher This Year

Motley Fool

Thu, 03/13/25 - 11:32 am

Summit Therapeutics

non-small cell lung cancer

Everest Medicines begins dosing in mRNA cancer vaccine trial

Clinical Trials Arena

Fri, 03/7/25 - 11:02 am

Everest Medicines

cancer vaccines

clinical trials

Moderna Eyes 2027 Launch for Cancer Vaccine Developed With Merck

MSN/Bloomberg

Wed, 03/5/25 - 11:26 pm

Moderna Therapeutics

clinical trials

Pages